132 related articles for article (PubMed ID: 34057119)
1. The comparison of Zn(II) arginine dithiocarbamate cytotoxicity in T47D breast cancer and fibroblast cells.
Prihantono P; Irfandi R; Raya I
Breast Dis; 2021; 40(S1):S55-S61. PubMed ID: 34057119
[TBL] [Abstract][Full Text] [Related]
2. Investigations of Ni(II)Cysteine-Tyrosine Dithiocarbamate Complex: Synthesis, Characterization, Molecular Docking, Molecular Dynamic, and Anticancer Activity on MCF-7 Breast Cancer Cell Line.
Pratiwi E; Raya I; Natsir H; Irfandi R; Taba P; Arfah R; Rasyid H; Hala Y; Kasim S; Khaerunnisa AB; Ilham B; Mazaya M; Tanzil Y; Luthfiana D
Asian Pac J Cancer Prev; 2024 Apr; 25(4):1301-1313. PubMed ID: 38679991
[TBL] [Abstract][Full Text] [Related]
3. Potential anticancer activity of Mn (II) complexes containing arginine dithiocarbamate ligand on MCF-7 breast cancer cell lines.
Prihantono ; Irfandi R; Raya I; Warsinggih
Ann Med Surg (Lond); 2020 Dec; 60():396-402. PubMed ID: 33235715
[TBL] [Abstract][Full Text] [Related]
4. Synthesis, Crystal Structures and Anticancer Studies of Morpholinyldithiocarbamato Cu(II) and Zn(II) Complexes.
Ajibade PA; Andrew FP; Botha NL; Solomane N
Molecules; 2020 Aug; 25(16):. PubMed ID: 32781741
[TBL] [Abstract][Full Text] [Related]
5. Characterization of a Zeolite-Y-Encapsulated Zn(II)Salmphen Complex with Targeted Anticancer Property.
Sakshi S; Dey S; Chowdhury S; Ray S
ACS Appl Mater Interfaces; 2023 Dec; 15(48):55518-55532. PubMed ID: 38010148
[TBL] [Abstract][Full Text] [Related]
6. A novel anticancer gold(III) dithiocarbamate compound inhibits the activity of a purified 20S proteasome and 26S proteasome in human breast cancer cell cultures and xenografts.
Milacic V; Chen D; Ronconi L; Landis-Piwowar KR; Fregona D; Dou QP
Cancer Res; 2006 Nov; 66(21):10478-86. PubMed ID: 17079469
[TBL] [Abstract][Full Text] [Related]
7. Cytotoxicity of bismuth(III) dithiocarbamate derivatives by promoting a mitochondrial-dependent apoptotic pathway and suppressing MCF-7 breast adenocarcinoma cell invasion.
Chan PF; Ang KP; Hamid RA
J Biol Inorg Chem; 2024 Mar; 29(2):217-241. PubMed ID: 38369679
[TBL] [Abstract][Full Text] [Related]
8. Synthesis, characterization, molecular docking studies of Mn(II)Prolinedithiocarbamate and its potential as anticancer agents.
Jarre S; Raya I; Prihantono ; Santi S
Mol Divers; 2024 Apr; 28(2):889-900. PubMed ID: 36913052
[TBL] [Abstract][Full Text] [Related]
9. Design anticancer potential of Zn(II)isoleucinedithiocarbamate complex on MCF-7 cell lines: synthesis, characterization, molecular docking, molecular dynamic, ADMET, and in-vitro studies.
Irfandi R; Raya I; Ahmad A; Fudholi A; Riswandi ; Santi S; Azalea WP; Putri SE; Alam MN; Supratman U; Olubode SO; Abdalrazaq EA; Kandeel M; Soekamto NH; Natsir H; Maming ; Ramlawati
Mol Divers; 2023 Oct; ():. PubMed ID: 37884781
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and characterization of Ni(II) and Zn(II) complexes of (furan-2-yl)methyl(2-(thiophen-2-yl)ethyl)dithiocarbamate (ftpedtc): X-ray structures of [Zn(ftpedtc)2(py)] and [Zn(ftpedtc)Cl(1,10-phen)].
Jamuna Rani P; Thirumaran S; Ciattini S
Spectrochim Acta A Mol Biomol Spectrosc; 2015 Feb; 137():1164-73. PubMed ID: 25305608
[TBL] [Abstract][Full Text] [Related]
11. Zn(ii), Cd(ii) and Hg(ii) saccharinate complexes with 2,6-bis(2-benzimidazolyl)pyridine as promising anticancer agents in breast and lung cancer cell lines via ROS-induced apoptosis.
Icsel C; Yilmaz VT; Aydinlik S; Aygun M
Dalton Trans; 2020 Jun; 49(23):7842-7851. PubMed ID: 32463408
[TBL] [Abstract][Full Text] [Related]
12. Synthesis, characterization and anticancer activity of gold(I) complexes that contain tri-tert-butylphosphine and dialkyl dithiocarbamate ligands.
Altaf M; Monim-ul-Mehboob M; Seliman AA; Sohail M; Wazeer MI; Isab AA; Li L; Dhuna V; Bhatia G; Dhuna K
Eur J Med Chem; 2015 May; 95():464-72. PubMed ID: 25841201
[TBL] [Abstract][Full Text] [Related]
13. Effect of glucosamine conjugation to zinc(II) complexes of a bis-pyrazole ligand: syntheses, characterization and anticancer activity.
Bhattacharyya S; Sarkar A; Dey SK; Mukherjee A
J Inorg Biochem; 2014 Nov; 140():131-42. PubMed ID: 25113858
[TBL] [Abstract][Full Text] [Related]
14. Exploring the cytotoxic activity of new phenanthroline salicylaldimine Zn(II) complexes.
Matos CP; Addis Y; Nunes P; Barroso S; Alho I; Martins M; Matos APA; Marques F; Cavaco I; Costa Pessoa J; Correia I
J Inorg Biochem; 2019 Sep; 198():110727. PubMed ID: 31195153
[TBL] [Abstract][Full Text] [Related]
15. New bipyridine gold(III) dithiocarbamate-containing complexes exerted a potent anticancer activity against cisplatin-resistant cancer cells independent of p53 status.
Altaf M; Monim-Ul-Mehboob M; Kawde AN; Corona G; Larcher R; Ogasawara M; Casagrande N; Celegato M; Borghese C; Siddik ZH; Aldinucci D; Isab AA
Oncotarget; 2017 Jan; 8(1):490-505. PubMed ID: 27888799
[TBL] [Abstract][Full Text] [Related]
16. Molecular mechanisms of apoptosis and cell selectivity of zinc dithiocarbamates functionalized with hydroxyethyl substituents.
Tan YS; Ooi KK; Ang KP; Akim AM; Cheah YK; Halim SN; Seng HL; Tiekink ER
J Inorg Biochem; 2015 Sep; 150():48-62. PubMed ID: 26086852
[TBL] [Abstract][Full Text] [Related]
17. Investigation of the Apoptosis Inducing and β-catenin Silencing by Tetradentate Schiff Base Zinc(II) Complex on the T-47D Breast Cancer Cells.
Majd MH; Guo X
Anticancer Agents Med Chem; 2023; 23(15):1740-1746. PubMed ID: 37171012
[TBL] [Abstract][Full Text] [Related]
18. Clioquinol and pyrrolidine dithiocarbamate complex with copper to form proteasome inhibitors and apoptosis inducers in human breast cancer cells.
Daniel KG; Chen D; Orlu S; Cui QC; Miller FR; Dou QP
Breast Cancer Res; 2005; 7(6):R897-908. PubMed ID: 16280039
[TBL] [Abstract][Full Text] [Related]
19. Suppression of survival in human SKBR3 breast carcinoma in response to metal-chelator complexes is preferential for copper-dithiocarbamate.
Viola-Rhenals M; Rieber MS; Rieber M
Biochem Pharmacol; 2006 Mar; 71(6):722-34. PubMed ID: 16412983
[TBL] [Abstract][Full Text] [Related]
20. Effects of electroporation on anticancer activity of 5-FU and newly synthesized zinc(II) complex in chemotherapy-resistance human brain tumor cells.
Alkış ME; Turan N; Alan Y; Irtegun Kandemir S; Buldurun K
Med Oncol; 2021 Sep; 38(11):129. PubMed ID: 34550481
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
